# Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC

> **NCT01803295** · NA · COMPLETED · sponsor: **UroGen Pharma Ltd.** · enrollment: 80 (actual)

## Conditions studied

- Carcinoma of Urinary Bladder, Superficial

## Interventions

- **DEVICE:** 40 mg MMC gel
- **OTHER:** Standard of care MMC mixed with water
- **DEVICE:** 80 mg MMC gel

## Key facts

- **NCT ID:** NCT01803295
- **Lead sponsor:** UroGen Pharma Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2016-07
- **Final completion:** 2017-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01803295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01803295, "Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01803295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*